OZOP ENERGY SOLUTIONS, INC. 10-K/A

ITEM 9A. CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures A review and evaluation was performed by the Company’s management, including the Company’s Chief Executive Officer (the “CEO”) and Chief Financial Officer (the “CFO”), as of the end of the period covered by this annual report on Form 10-K, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this annual report. Based on that review and evaluation, the CEO and CFO have concluded that as of December 31, 2021, disclosure controls and procedures were not effective at ensuring that the material information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported as required in the application of SEC rules and forms. Management’s Report on Internal Controls over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Internal control over financial reporting is a set of processes designed by, or under the supervision of, a company’s principal executive and principal financial officers, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes those policies and procedures that: ● Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and disposition of our assets; 19 ● Provide reasonable assurance our transactions are recorded as necessary to permit preparation of our financial statements in accordance with GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and ● Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. It should be noted that any system of internal control, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Our CEO and CFO have evaluated the effectiveness of our internal control over financial reporting as described in Exchange Act Rules 13a-15(e) and 15d-15(e) as of the end of the period covered by this report based upon criteria established in “Internal Control-Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). As a result of this evaluation, we concluded that our internal control over financial reporting was not effective as of December 31, 2021, as described below. We assessed the effectiveness of the Company’s internal control over financial reporting as of evaluation date and identified the following material weaknesses: Insufficient Resources: We have an inadequate number of personnel with requisite expertise in the key functional areas of finance and accounting. Inadequate Segregation of Duties : We have an inadequate number of personnel to properly implement control procedures. Lack of Audit Committee: We do not have a functioning audit committee, resulting in lack of independent oversight in the establishment and monitoring of required internal controls and procedures. We are committed to improving the internal controls and will (1) consider using third party specialists to address shortfalls in staffing and to assist us with accounting and finance responsibilities, (2) increase the frequency of independent reconciliations of significant accounts which will mitigate the lack of segregation of duties until there are sufficient personnel and (3) may consider appointing additional outside directors and audit committee members in the future. We have discussed the material weakness noted above with our independent registered public accounting firm. Due to the nature of these material weaknesses, there is a more than remote likelihood that misstatements which could be material to the annual or interim financial statements could occur that would not be prevented or detected. This Annual Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our independent registered public accounting firm pursuant to the rules of the SEC that permit us to provide only management’s report in this annual report. Changes in Internal Control over Financial Reporting There have been no changes in the Company’s internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting. ITEM 9B. OTHER INFORMATION None. OFF BALANCE SHEET ARRANGEMENTS We have no off-balance sheet arrangements including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits. 20 PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE Identification of directors and executive officers . The names and ages of our directors and executive officers are set forth below. Also included is their principal occupation(s). Our By-Laws provide for up to four directors. All directors are elected annually by the stockholders to serve until the next annual meeting of the stockholders and until their successors are duly elected and qualified. Name Age Position Beginning Brian Conway 51 Chief Executive Officer and Interim Chief Financial Officer February 28, 2020 Brian P. Conway, the Chief Executive Officer and Interim Chief Financial Officer brings 20 years of proven success in marketing and business development for both private and publicly traded companies. Starting off in database management and sales for Venture Direct on Madison Avenue, he crossed over to Wall Street as a co-founder of Waypoint Capital Partners. During this time, he was responsible for national sales, marketing, business and product development, national account customers, and new business relations with international and US companies while creating awareness for public companies with many of the nation’s top public relations firms. From October 1, 2014, through August 31, 2019, Mr. Conway was the CEO, CFO and Director of Ngen Technologies, Inc. (f/k/a/ Liberated Solutions, Inc.). His relationships and experience with investment bankers, non-dilutive financing, and public relations should be instrumental in moving the Company forward. Family Relationships None Involvement in Certain Legal Proceedings No director, executive officer, significant employee or control person of the Company has been involved in any legal proceeding listed in Item 401(f) of Regulation S-K in the past 10 years. Corporate Governance Our Board has not established any committees, including an audit committee, a compensation committee or a nominating committee, or any committee performing a similar function. The functions of those committees are being undertaken by our Board. Because we do not have any independent directors, our Board believes that the establishment of committees of our Board would not provide any benefits to our Company and could be considered more form than substance. Given our relative size and lack of directors’ and officers’ insurance coverage, we do not anticipate that any of our stockholders will make such a recommendation in the near future. While there have been no nominations of additional directors proposed, in the event such a proposal is made, all current members of our Board will participate in the consideration of director nominees. As with most small, early stage companies until such time as our Company further develops our business, achieves a revenue base and has sufficient working capital to purchase directors’ and officers’ insurance, we do not have any immediate prospects to attract independent directors. When we are able to expand our Board to include one or more independent directors, we intend to establish an audit committee of our Board of Directors. It is our intention that one or more of these independent directors will also qualify as an audit committee financial expert. Our securities are not quoted on an exchange that has requirements that a majority of our Board members be independent and we are not currently otherwise subject to any law, rule or regulation requiring that all or any portion of our Board of Directors include “independent” directors, nor are we required to establish or maintain an audit committee or other committee of our Board. 21 Code of Ethics We adopted a Code of Ethics for Senior Financial Management to promote honest and ethical conduct and to deter wrongdoing. This Code applies to our Chief Executive Officer and Chief Financial Officer and other employees performing similar functions. The obligations of the Code of Ethics supplement, but do not replace, any other code of conduct or ethics policy applicable to our employees generally. Under the Code of Ethics, all members of the senior financial management shall: ● Act honestly and ethically in the performance of their duties at our company, ● Avoid actual or apparent conflicts of interest between personal and professional relationships, ● Provide full, fair, accurate, timely and understandable disclosure in reports and documents that we file with, or submits to, the SEC and in other public communications by our company, ● Comply with rules and regulations of federal, state and local governments and other private and public regulatory agencies that effect the conduct of our business and our financial reporting, ● Act in good faith, responsibly, with due care, competence and diligence, without misrepresenting material facts or allowing the member’s independent judgment to be subordinated ● Respect the confidentiality of information in the course of work, except when authorized or legally obtained to disclosure such information, ● Share knowledge and maintain skills relevant to carrying out the member’s duties within our company, ● Proactively promote ethical behavior as a responsible partner among peers and colleagues in the work environment and community, ● Achieve responsible use of and control over all assets and resources of our company entrusted to the member, and ● Promptly bring to the attention of the Chief Executive Officer any information concerning (a) significant deficiencies in the design or operating of internal controls which could adversely affect to record, process, summarize and report financial data or (b) any fraud, whether or not material, that involves management or other employees who have a significant role in our financial reporting or internal controls. Director Independence None of the members of our Board of Directors qualifies as an independent director in accordance with the published listing requirements of the NASDAQ Global Market. The NASDAQ independence definition includes a series of objective tests, such as that the director is not, and has not been for at least three years, one of our employees and that neither the director, nor any of his family members has engaged in various types of business dealings with us. In addition, our Board has not made a subjective determination as to each director that no relationships exist which, in the opinion of our Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director, though such subjective determination is required by the NASDAQ rules. Had our Board of Directors made these determinations, our Board would have reviewed and discussed information provided by the directors and us with regard to each director’s business and personal activities and relationships as they may relate to us and our management. In performing the functions of the audit committee, our board oversees our accounting and financial reporting process. In this function, our board performs several functions. Our board, among other duties, evaluates and assesses the qualifications of the Company’s independent auditors; determines whether to retain or terminate the existing independent auditors; meets with the independent auditors and financial management of the Company to review the scope of the proposed audit and audit procedures on an annual basis; reviews and approves the retention of independent auditors for any non-audit services; reviews the independence of the independent auditors; reviews with the independent auditors and with the Company’s financial accounting personnel the adequacy and effectiveness of accounting and financial controls and considers recommendations for improvement of such controls; reviews the financial statements to be included in our annual and quarterly reports filed with the Securities and Exchange Commission; and discusses with the Company’s management and the independent auditors the results of the annual audit and the results of our quarterly financial statements. 22 Our board as a whole will consider executive officer compensation, and our entire board participates in the consideration of director compensation. Our board as a whole oversees our compensation policies, plans and programs, reviews and approves corporate performance goals and objectives relevant to the compensation of our executive officers, if any, and administers our equity incentive and stock option plans, if any. Each of our directors participates in the consideration of director nominees. In addition to nominees recommended by directors, our board will consider nominees recommended by shareholders if submitted in writing to our secretary. Our board believes that any candidate for director, whether recommended by shareholders or by the board, should be considered on the basis of all factors relevant to our needs and the credentials of the candidate at the time the candidate is proposed. Such factors include relevant business and industry experience and demonstrated character and judgment. Compliance with Section 16(a) of the Securities Exchange Act of 1934 Section 16(a) of the Securities Exchange Act of 1934 requires the Company’s directors and executive officers, persons who beneficially own more than 10% of a registered class of the Company’s equity securities, and certain other persons to file reports of ownership and changes in ownership on Forms 3, 4 and 5 with the SEC, and to furnish the Company with copies of the forms. The Company does not believe that all of its directors, executive officers and greater than 10% beneficial owners complied with all such filing requirements during 2021. ITEM 11. EXECUTIVE COMPENSATION EXECUTIVE COMPENSATION SUMMARY COMPENSATION TABLE The following table sets forth information regarding compensation earned in or with respect to our fiscal years 2021 and 2020: (i) our principal executive officer or other individual serving in a similar capacity during the fiscal years 2021, and 2020; (ii) our two most highly compensated executive officers other than our principal executive officers who were serving as executive officers at December 31, 2021, and 2020, whose compensation exceed $100,000; and (iii) up to two additional individuals for whom disclosure would have been required but for the fact that the individual was not serving as an executive officer at December 31, 2021. Compensation information is shown for the fiscal years ended December 31, 2021, and 2020: Name and Principal Position Year Salary Bonus Stock Awards Option Awards All Other Compensation Total Brian P Conway (1) 2021 $ 280,000 $ 532,099 $ 2,850,000 $ — $ — $ 3,662,099 2020 $ 377,804 $ — $ 4,286,648 $ — $ — $ 4,664,452 Catherine Chis (2) 2021 $ 141,666 $ — $ — $ — $ — $ 141,666 2020 $ 83,500 $ — $ — $ — $ — $ 83,500 (1) On February 28, 2020, Mr. Conway was appointed as the Company’s Chief Executive Officer. (2) Ms. Chis was the CEO of PCTI from 2018 until her resignation in July 2021. 2021 OPTION GRANTS There were no options to purchase shares of our Common Stock issued and outstanding as of December 31, 2021, or December 31, 2020. OUTSTANDING EQUITY AWARDS AT 2021 FISCAL YEAR-END There were no outstanding equity awards for the years ended December 31, 2021, and 2020. 23 EXECUTIVE EMPLOYMENT AGREEMENTS On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the “Employment Agreement”). Pursuant to the terms of the Employment Agreement, Mr. Conway received an initial annual salary of $120,000, for his position of CEO of the Company, payable monthly. Mr. Conway was also issued 2,500 shares of Series C Preferred Stock. The Company valued the shares at $5,000. On August 28, 2020, Mr. Conway was issued 1,333 shares of Series D Preferred stock and 500 shares of series E Preferred Stock. At the time of issuance the aggregate shares of Series D Preferred Stock in its entirety, is convertible into three times the number of shares of common stock outstanding at the time of conversion. On August 28, 2020, Mr. Conway owned 6.67% of the issued and outstanding Series D Preferred Stock, and based on the 3,107,037,634 shares outstanding on August 28, 2020, Mr. Conway’s Preferred Stock was convertible into 621,253,401 shares of common stock. Based on the share price of the common stock on that date of $0.0065, the shares were valued at $4,286,648 and recognized as compensation during the year ended December 31, 2020. Effective January 1, 2021, Mr. Conway’s compensation is $20,000 per month, and on September 1, 2021, Mr. Conway began receiving $10,000 per month from Ozop Capital. Other than the foregoing, at this time, we do not have any written employment agreement or other formal compensation agreements with our officers and directors. Compensation arrangements are the subject of ongoing development and we will make appropriate additional disclosures as they are further developed and formalized. DIRECTOR COMPENSATION Director Compensation Policies We have not compensated our directors for their service on our Board from our inception through fiscal 2020. There are no arrangements currently in place pursuant to which directors will be compensated in the future for any services provided as a director. ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table shows the beneficial ownership of the Company’s shares as of April 14, 2022, (unless otherwise noted) by (i) each person known by the Company to own beneficially more than 5% of the outstanding shares, (ii) each director and director nominee of the Company, (iii) each executive officer of the Company named in the Summary Compensation Table (the “Named Executive Officers” or “NEOs”), and (iv) all executive officers and directors of the Company as a group. The table includes shares that may be acquired within 60 days of April 14, 2022, upon the exercise of stock options by employees or outside directors and shares of restricted stock. Unless otherwise indicated, each of the persons or entities listed below exercises sole voting and dispositive power over the shares that each of them beneficially owns. For the beneficial ownership of the stockholders owning 5% or more of the shares, the Company relied on publicly available filings and representations of the stockholders. Name and Title: Class of Security Amount of beneficial ownership Percent of Class (1) Executive Officers and Directors: Brian P Conway, CEO and Director (2) Common Stock 2,022,410,243 30.4 % Series C Preferred Stock 2,500 100.0 % Series D Preferred Stock 1,333 99.9 % (1) Percentages are based on 4,622,362,997 shares of the Company’s common stock, 2,500 shares of Series C Preferred Stock and 1,334 shares of Series D Preferred stock issued and outstanding as of April 14, 2022. The voting rights associated with the Series C Preferred Stock in the aggregate are equal to 67% of the total vote. Series C Preferred Stock has no conversion rights. Any holder may, at any time convert any number of shares of Series D Convertible Preferred Stock held by such holder into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 1.5 and dividing that number by the number of authorized shares of Series D Convertible Preferred Stock multiplied by the number of Series D shares being converted. Series D Preferred Stock has no voting rights. (2) Includes 1,333 shares of Series D Preferred Stock convertible into 2,022,410,243 shares of common stock. 24 Item 13. Certain Relationships and Related Transactions For the years ended December 31, 2021, and 2020, the Company recorded expenses to its officers in the following amounts: Year ended December 31, 2021 2020 CEO, parent $ 812,099 $ 377,804 CEO, parent- Series E Preferred Stock 2,850,000 - CEO, parent- Series D Preferred Stock - 4,286,648 President, subsidiary (resigned July 2021) 141,666 83,500 Total $ 3,803,765 $ 4,747,952 As of December 31, 2020, included in related party payable is $9,120 for the amount owed the former CEO of PCTI. Item 14. Principal Accountant Fees and Services The following is a summary of the fees billed to us by Prager Metis CPAs LLC, our independent registered public accounting firm, for professional services rendered for the fiscal years ended December 31, 2021, and 2020. 2021 2020 Audit Fees (1) $ 76,000 $ 54,500 Total Fees $ 76,000 $ 54,500 (1) Audit Fees are fees paid for professional services rendered for the audit of the Company’s annual consolidated financial statements, reviews of the Company’s interim consolidated financial statements and statutory audit requirements at certain non-U.S. locations. PART IV Item 15. Exhibits, Financial Statement Schedules (a) 1. Financial Statements The financial statements and Reports of Independent Registered Public Accounting Firms are listed in the “Index to Financial Statements and Schedules” on page F-1 and included on pages F-2 to F-30. 2. Financial Statement Schedules All schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission (the “Commission”) are either not required under the related instructions, are not applicable (and therefore have been omitted), or the required disclosures are contained in the financial statements included herein. 3. Exhibits (including those incorporated by reference). 25 Exhibit No. Description 2.1 Share Exchange Agreement dated April 5, 2018 by and among Newmarkt Corp., the shareholders of Ozop Surgical, Inc., Ozop Surgical, Inc. and Denis Razvodovskij (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on April 19, 2018). 2.2 Stock Purchase Agreement dated June 26, 2020, by and among Ozop Surgical Corp., Power Conversion Technologies, Inc. and Catherine Chis (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on June 29, 2020). 2.3 Merger Agreement and Plan of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on November 13, 2020). 3.1 Articles of Incorporation (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016) 3.2 Bylaws (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016) 3.3 Certificate of Amendment of Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on May 8, 2018 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on May 14, 2018). 3.4 Certificate of Designations for Series B Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on April 2, 2019). 3.5 Amended and Restated Bylaws of Ozop Surgical Corp. adopted on May 22, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on May 22, 2019). 3.6 Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on July 25, 2019. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 30, 2019). 3.7 Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on September 24, 2019). 3.8 Certificate of Withdrawal of Series B Preferred Stock. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on September 24, 2019). 3.9 Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on October 29, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on October 31, 2019). 3.10 Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on December 30, 2020, (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on December 31, 2019). 3.11 Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on January 21, 2020. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 7, 2020). 26 3.12 Amended and Restated Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2020). 3.13 Amendment to Certificate of Designation of Series C Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 10, 2020). 3.14 Certificate of Designation of Series D Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on July 10, 2020). 3.15 Certificate of Designation of Series E Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K filed on July 10, 2020). 3.16 Articles of Incorporation of Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on November 13, 2020). 3.17 Articles of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on November 13, 2020). 3.18 Amended and Restated Certificate of Designation Series D Preferred Stock dated July 27, 2021 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on August 2, 2021). 3.19 Advisory agreement between Ozop Capital and RMA dated September 1, 2021 (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on September 2, 2021) 10.1 Binding Letter of Intent dated February 28, 2020, by and between Ozop Surgical Corp. and Power Conversion Technologies, Inc, and Catherine Chis, (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 28, 2020). 10.2+ Employment Agreement dated February 28, 2020, by and between Ozop Surgical Corp. and Brian Conway, (Incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K filed on February 28, 2020). 31.1* Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2* Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1* Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63 101.INS* Inline XBRL Instance Document 101.SCH* Inline XBRL Taxonomy Extension Schema Document 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Filed herewith. + Management contract or compensatory plan or arrangement. ITEM 16. FORM 10-K SUMMARY Not applicable. 27 Signatures Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Ozop Energy Solutions, Inc. By: /s/ Brian P. Conway Brian P. Conway Chief Executive Officer Date: April 26, 2022 Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. Signature Title Date /s/ Brian P. Conway Brian P. Conway Chairman and Chief Executive Officer (principal executive officer) April 26, 2022 28 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED FINANCIAL STATEMENTS Table of Contents Page Reports of Independent Registered Public Accounting Firm (PCAOB ID # 237 ) F-2 Consolidated Balance Sheets as of December 31, 2021 and 2020 F-3 Consolidated Statements of Comprehensive Loss for the years ended December 31, 2021 and 2020 F-4 Consolidated Statements of Stockholders’ Deficit as of December 31, 2021 and 2020 F-5 Consolidated Statements of Cash Flows for the years ended December 31, 2021 and 2020 F-6 Notes to Consolidated Financial Statements F-7 F- 1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Ozop Energy Solutions, Inc. Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated balance sheets of Ozop Energy Solutions, Inc. (the Company) as of December 31, 2021, and 2020, and the related consolidated statements of comprehensive loss, stockholders’ equity (deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and 2020, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America. Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note 3 to the consolidated financial statements, As of December 31, 2021, the Company had an accumulated deficit of $217,326,611 and a working capital deficit of $28,225,908 (including derivative liabilities of $20,966,701). As of December 31, 2021, the Company was in default of $1,973,847 and accrued interest on debt instruments due to non-payment upon maturity dates, and subsequent to December 31, 2021, an additional $13,310,000 and accrued interest on debt instruments also were in default status due to non-payment upon maturity dates. These factors, among others, raise substantial doubt regarding the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2 to the accompanying financial statements. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. Critical Audit Matters The critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters. /s/ Prager Metis CPA’s LLC We have served as the Company’s auditor since 2018 Hackensack, New Jersey April 15, 2022 F- 2 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED BALANCE SHEET 2021 2020 December 31, 2021 2020 ASSETS Current Assets Cash $ 6,767,167 $ 1,808,476 Prepaid assets 151,998 9,569 Accounts receivable 1,299,334 400 Inventory 1,065,982 359,347 Vendor deposits 874,627 - Total Current Assets 10,159,108 2,177,792 Operating lease right-of-use asset, net 707,686 149,529 Property and equipment, net 132,889 60,671 Other Assets 568,249 - TOTAL ASSETS $ 11,567,932 $ 2,387,992 LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Liabilities Current Liabilities Accounts payable and accrued expenses $ 3,246,342 $ 1,678,007 Related party liabilities - 9,120 Convertible notes payable, net of discounts 25,000 1,078,985 Current portion of notes payable, net of discounts 13,011,307 1,130,083 Customer deposits 169,849 188,518 Deferred liability 750,000 750,000 Derivative liabilities 20,966,701 3,299,684 Operating lease liability, current portion 194,366 75,340 Current portion of deferred revenues 21,451 17,876 Total Current Liabilities 38,385,016 8,227,613 Long Term Liabilities Note payable, net of discount 389,423 389,423 Operating lease liability, net of current portion 517,890 74,189 Deferred revenue, net of current portion 25,026 46,477 TOTAL LIABILITIES 39,317,355 8,737,702 COMMITMENTS AND CONTINGENCIES - - Stockholders’ Equity (Deficit) Preferred stock ( 10,000,000 shares authorized, par value $ 0.001 ) Series C Preferred Stock ( 50,000 shares authorized and 2,500 (2021) and 50,000 (2020) shares issued and outstanding, par value $ 0.001 ) 3 50 Series D Preferred Stock ( 4,570 (2021) and 20,000 (2020) shares authorized and 1,334 (2021) and 20,000 (2020) shares issued and outstanding, par value $ 0.001 ) 1 20 Series E Preferred Stock ( 3,000 shares authorized, - 0 - (2021) and 1,000 (2020) issued and outstanding, par value $ 0.001 ) - 1 Preferred stock Value Common stock ( 4,990,000,000 shares authorized par value $ 0.001 ; 4,617,362,997 (2021) and 3,397,958,292 (2020) shares issued and outstanding) 4,617,363 3,397,958 Common stock to be issued; 637,755 shares as of December 31, 2021 638 - Additional paid in capital 196,464,222 12,530,933 Treasury Stock ( 11,249,934 ) - Accumulated Deficit ( 217,326,611 ) ( 22,278,665 ) Accumulated comprehensive loss - ( 7 ) Total Ozop Energy Systems, Inc. stockholders’ equity (deficit) ( 27,494,318 ) ( 6,349,710 ) Noncontrolling interest ( 255,105 ) - TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) ( 27,749,423 ) ( 6,349,710 ) TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) $ 11,567,932 $ 2,387,992 See notes to consolidated financial statements. F- 3 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) 2021 2020 For the Year Ended December 31, 2021 2020 Revenue $ 11,928,605 $ 1,411,432 Cost of goods sold 10,342,413 1,404,358 Gross profit 1,586,192 7,074 Operating expenses: General and administrative, related parties 3,803,765 4,747,952 General and administrative, other 10,584,176 1,311,172 Impairment of intangible assets - 11,526,303 Total operating expenses 14,387,941 17,585,427 Loss from operations ( 12,801,749 ) ( 17,578,353 ) Other (income) expenses: Interest expense 53,252,232 3,409,393 Loss on change in fair value of derivatives 17,349,076 176,050 (Gain) loss on extinguishment of debt 95,449,994 ( 195,553 ) Debt restructure expense 16,450,000 - Total Other (Income) Expenses 182,501,302 3,389,890 Income (loss) before income taxes ( 195,303,051 ) ( 20,968,243 ) Income tax provision - - Net Income (loss) ( 195,303,051 ) ( 20,968,243 ) Less: net loss attributable to noncontrolling interest ( 255,105 ) - Net loss attributable to Ozop Energy Solutions, Inc. $ ( 195,047,946 ) $ ( 20,968,243 ) Other comprehensive loss: Foreign currency translation adjustment - ( 7 ) Comprehensive income (loss) ( 195,303,051 ) ( 20,968,250 ) Less: comprehensive loss attributable to noncontrolling interest ( 255,105 ) - Comprehensive loss attributable to Ozop Energy Solutions, Inc. $ ( 195,047,946 ) $ ( 20,968,250 ) Income (loss) per share basic and fully diluted $ ( 0.04 ) ( 0.02 ) Weighted average shares outstanding Basic and diluted 4,442,045,075 1,110,673,228 See notes to consolidated financial statements. F- 4 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) YEAR ENDED DECEMBER 31, 2021 Shares Amount Shares Amount Shares Amount Shares Amount Shares Amount Stock Loss Capital Deficit Interest (Deficit) Common stock to be issued Series C Preferred Stock Series D Preferred Stock Series E Preferred Stock Common Stock Treasury Accumulated Comprehensive Additional Paid-in Accumulated Noncontrolling Total Stockholders’ Equity Shares Amount Shares Amount Shares Amount Shares Amount Shares Amount Stock Loss Capital Deficit Interest (Deficit) Balances January 1, 2021 - $ - 50,000 $ 50 20,000 $ 20 1,000 $ 1 3,397,958,292 $ 3,397,958 $ - ( 7 ) $ 12,530,933 $ ( 22,278,665 ) $ - $ ( 6,349,710 ) Shares issued for conversions of notes and interest payable - - - - - - - - 483,154,618 483,155 - 102,055,875 - - 102,539,030 Shares issued upon cashless exercise of warrants - - - - - - - - 405,797,987 405,798 - 47,704,503 - - 48,110,301 Issuance of Series E Preferred Stock - - - - - - 4,000 4 - - - 3,999,996 - - 4,000,000 Redemption of Series E Preferred Stock - - - - - - ( 5,000 ) ( 5 ) - - - ( 4,999,995 ) - - ( 5,000,000 ) Shares issued and to be issued for fees and services 637,755 638 - - - - - - 55,452,080 55,452 - 5,267,910 - - 5,324,000 Shares issued for lease agreement - - - - - - - - 100,000,000 100,000 - 530,000 - - 630,000 Shares issued for debt restructure - - - - - - - - 175,000,000 175,000 - 16,275,000 - - 16,450,000 Purchase of Series C and Series D stock for Treasury - - ( 47,500 ) ( 48 ) ( 18,667 ) ( 19 ) - - - - ( 11,249,934 ) - - - - ( 11,250,000 ) Sale of Series D Preferred Stock and warrants - - - - 1 - - - - - - - 13,100,000 - - 13,100,000 Foreign currency translation adjustment - - - - - - - - - - - 7 - - - 7 Net loss - - - - - - - - - - - - - ( 195,047,946 ) ( 255,105 ) ( 195,303,051 ) Balances December 31, 2021 637,755 $ 638 2,500 $ 3 1,334 $ 1 - $ - 4,617,362,977 $ 4,617,363 $ ( 11,249,934 ) $ - $ 196,464,222 $ ( 217,326,611 ) $ ( 255,105 ) $ ( 27,749,423 ) OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) YEAR ENDED DECEMBER 31, 2020 Common stock to be issued Series C Preferred Stock Series D Preferred Stock Series E Preferred Stock Common Stock Treasury Accumulated Comprehensive Additional Paid-in Accumulated Noncontrolling Total Stockholders’ Equity Shares Amount Shares Amount Shares Amount Shares Amount Shares Amount Stock Income Capital Deficit Interest (Deficit) Balances January 1, 2020 - - 47,500 $ 48 18,667 $ 19 500 $ 1 - $ - - $ - $ 76,922 $ ( 1,310,422 ) - $ ( 1,233,434 ) Balance - - 47,500 $ 48 18,667 $ 19 500 $ 1 - $ - - $ - $ 76,922 $ ( 1,310,422 ) - $ ( 1,233,434 ) Reverse merger transaction - - - - - - 1,851,930,729 1,851,931 - ( 1,033,489 ) - 818,442 Shares issued for conversions of note and interest payable - - - - - - 1,411,815,206 1,411,815 - 9,140,571 - 10,552,386 Shares issued upon cashless exercise of warrants - - - - - - 134,212,357 134,212 - ( 134,212 ) - - Warrants issued in connection with issuance of debt - - - - - - - - - 194,495 - 194,495 Shares issued pursuant to CEO contract 2,500 3 1,333 1 500 1 - - - 4,286,646 - 4,286,651 Foreign currency translation adjustment - - - - - - - - ( 7 ) - - ( 7 ) Net loss - - - - - - - - - - - - - ( 20,968,243 ) - ( 20,968,243 ) Balances December 31, 2020 - - 50,000 $ 50 20,000 $ 20 1,000 $ 1 3,397,958,292 $ 3,397,958 - $ ( 7 ) $ 12,530,933 $ ( 22,278,665 ) - $ ( 6,349,710 ) Balance - - 50,000 $ 50 20,000 $ 20 1,000 $ 1 3,397,958,292 $ 3,397,958 - $ ( 7 ) $ 12,530,933 $ ( 22,278,665 ) - $ ( 6,349,710 ) See notes to consolidated financial statements. F- 5 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED STATEMENT OF CASH FLOWS 2021 2020 For the Year Ended December 31, 2021 2020 Cash flows from operating activities: Net loss from continuing operations $ ( 195,303,051 ) $ ( 20,968,243 ) Adjustments to reconcile net loss to net cash used in operations Non-cash interest expense 51,492,115 2,915,952 Amortization and depreciation 189,348 68,299 Debt restructure expense 16,450,000 - Loss on fair value change of derivatives 17,349,075 176,050 Loss (gain) on extinguishment of debt 95,449,994 ( 195,553 ) Stock compensation expense 9,322,751 4,286,647 Impairment - 11,526,303 Changes in operating assets and liabilities: Accounts receivable ( 1,298,934 ) 19,374 Inventory ( 706,635 ) 612,466 Prepaid expenses ( 79,430 ) 6,512 Vendor deposits ( 874,627 ) - Accounts payable and accrued expenses 1,818,095 207,937 Deferred revenue ( 17,876 ) 64,353 Operating lease liabilities ( 140,161 ) ( 35,609 ) Customer deposits ( 18,670 ) ( 496,304 ) Net cash used in operating activities ( 6,368,006 ) ( 1,811,816 ) Cash flows from investing activities: Cash acquired in acquisition - 470,849 Purchase of office and computer equipment ( 116,836 ) ( 46,418 ) Net cash used in (provided by) investing activities ( 116,836 ) 424,431 Cash flows from financing activities: Proceeds from issuances of convertible notes payable - 489,000 Proceeds from issuances of notes payable 15,000,000 1,553,000 Proceeds from sale of Series D preferred stock and warrants 13,100,000 - Proceeds from Payroll Protection Program - 100,400 Proceeds from Economic Disaster Loan - 10,000 Proceeds received on deferred liability - 750,000 Proceeds from shareholders - 42,420 Payments to shareholders ( 13,634 ) ( 74,470 ) Payments of principal of convertible note payable and notes payable ( 392,833 ) ( 101,863 ) Redemption of Series E Preferred Stock ( 5,000,000 ) - Redemption of Series C and Series D Preferred Stock ( 11,250,000 ) - Advance from affiliate - 400,000 Net cash provided by financing activities 11,443,533 3,168,487 Effects of exchange rate on cash - ( 7 ) Net increase in cash 4,958,691 1,781,094 Cash, Beginning of year 1,808,476 27,382 Cash, End of year $ 6,767,167 $ 1,808,476 Supplemental disclosure of cash flow information: Cash paid for interest $ 126,707 $ 133,300 Cash paid for income taxes $ - $ - Schedule of non-cash Investing or Financing Activity: Original issue discount included in notes payable $ 1,610,000 $ 548,333 Issuance of common stock upon convertible note and accrued interest conversion $ 743,555 $ 2,383,801 Operating lease right-of-use assets and liabilities $ 702,888 $ 185,139 Issuance of common stock and preferred stock for consulting fees and compensation $ 9,322,751 $ 4,286,647 Issuance of common stock for lease agreement $ 630,000 $ - Issuance of common stock for debt restructuring $ 16,450,000 $ - See notes to consolidated financial statements. F- 6 OZOP ENERGY SOLUTIONS, INC. Notes to Consolidated Financial Statements December 31, 2021 NOTE 1 - ORGANIZATION Business Ozop Energy Solutions, Inc. (the” Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada. On October 29, 2020, the Company formed a new wholly owned subsidiary, Ozop Surgical Name Change Subsidiary, Inc., a Nevada corporation (“Merger Sub”). The Merger Sub was formed under the Nevada Revised Statutes for the sole purpose and effect of changing the Company’s name to “Ozop Energy Solutions, Inc.” That same day the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the Merger Sub and filed Articles of Merger (the “Articles of Merger”) with the Nevada Secretary of State, merging the Merger Sub into the Company, which were stamped effective as of November 3, 2020. As permitted by the Section 92.A.180 of the Nevada Revised Statutes, the sole purpose and effect of the filing of Articles of Merger was to change the name of the Company from Ozop Surgical Corp to “Ozop Energy Solutions, Inc.” On December 11, 2020, the Company formed Ozop Energy Systems, Inc. (“OES”), a Nevada corporation and a wholly owned subsidiary of the Company. OES was formed to be a manufacturer and distributor of renewable energy products. On August 19, 2021, the Company formed Ozop Capital Partners, Inc. (“Ozop Capital”), a Delaware corporation. The Company is the majority shareholder of Ozop Capital with PJN Holdings LLC (“PJN”), a New York limited liability company, being the minority shareholder. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital. On October 29, 2021, EV Insurance Company, Inc. (“EVCO”) was formed as a captive insurance company in the State of Delaware. EVCO is a wholly owned subsidiary of Ozop Capital. On January 7, 2022, EVCO filed with New Castle County, Delaware DBA OZOP Plus. Stock Purchase Agreement On July 10, 2020, the Company entered into a Stock Purchase Agreement (the “SPA”) with Power Conversion Technologies, Inc., a Pennsylvania corporation (“PCTI”), and Catherine Chis (“Chis”), PCTI’s Chief Executive Officer (“CEO”) and its sole shareholder. Under the terms of the SPA, the Company acquired one thousand ( 1,000 ) shares of PCTI, which represents all of the outstanding shares of PCTI, from Chis in exchange for the issuance of 47,500 shares of the Company’s Series C Preferred Stock, 18,667 shares of the Company’s Series D Preferred Stock, and 500 shares of the Company’s Series E Preferred Stock to Chis. The Acquisition was accounted for as a business combination and was treated as a reverse acquisition for accounting purposes with PCTI as the accounting acquirer in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”). In accordance with the accounting treatment for a reverse acquisition, the Company’s historical financial statements prior to the reverse merger were and will be replaced with the historical financial statements of PCTI prior to the reverse merger, in all future filings with the U.S. Securities and Exchange Commission (the “SEC”). The consolidated financial statements after completion of the reverse merger have and will include the assets, liabilities and results of operations of the combined company from and after the closing date of the reverse merger. PCTI designs, develops, manufactures and distributes standard and custom power electronic solutions. PCTI serves clients in several industries including energy storage, shore power, DEWs, microgrid, telecommunications, military, transportation, renewable energy, aerospace and mission critical defense systems. Customers include the United States military and other global military organizations. All of its products are manufactured in the United States. Because of the Company’s product scope and the high-power niche that their products occupy, the Company is targeting the rapidly growing renewable and energy storage markets. The Company’s mission is to be a global leader for high power electronics with a standard of continued innovation. F- 7 The Company utilized the Option Pricing Method (the “OPM”) to value the transaction. The OPM method treats all equity linked instruments as call options on the enterprise value, with exercise prices and liquidation preferences based on the terms of the various common, preferred, options, warrants, and convertible debt. Under this method, the common stock only has value if the funds available for distribution to the shareholders exceed the liquidation preferences of the preferred stock and face value of the convertible debt. The timing of a liquidity event is required to utilize this method. The OPM considers the various terms of the stockholder agreements—including the level of seniority among the securities, dividend policy, conversion ratios, and cash allocations—upon liquidation of the enterprise. In addition, the method implicitly considers the effect of the liquidation preference as of the future liquidation date, not as of the valuation date. A feature of the OPM is that it explicitly recognizes the option-like payoffs of the various share classes utilizing information in the underlying asset (that is, estimated volatility) and the risk-free rate to adjust for risk by adjusting the probabilities of future payoffs. The following table summarizes the preliminary value of the consideration issued and the preliminary purchase price allocation of the fair value of assets acquired and liabilities assumed in the transaction. SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED Purchase Price Allocation Fair value of OZOP equity consideration issued $ 818,444 Assets acquired $ 1,229,917 Goodwill 11,201,145 Liabilities assumed ( 11,612,618 ) Total purchase price allocation $ 818,444 The Company reviews the goodwill allocated to each of our reporting units for possible impairment annually and whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Pursuant to that review, management has determined that the goodwill arising from the above transaction has been impaired and accordingly $ 11,201,145 was recorded as an impairment expense for the year ended December 31, 2020. NOTE 2 – RESTATEMENT During the preparation of the financial statements as of March 31, 2021, and for the three months ended March 31, 2021, the Company discovered an error was made in the financial statements as of and for the period ended December 31, 2020. The error relates to the recognition of certain warrants as derivative liabilities due to the fact the Company has insufficient authorized shares to cover the exercises. Management believes that the error as of and for December 31, 2020, does not materially impact the balance sheet as December 31, 2020. New warrants issued in the year ended December 31, 2021, have been properly accounted for as derivatives, when necessary. The following table reflects the effect of the error on the balance sheet as of December 31, 2020: SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS Adjusted December 31, 2020 December 31, 2020 Total assets $ 2,387,992 $ 2,387,992 Current liabilities 8,227,613 6,885,845 Total liabilities 8,737,702 7,395,934 Total stockholders’ deficit ( 6,349,710 ) ( 5,007,942 ) The change in the current and total liabilities is as a result of the fair value of $ 2,061,307 of warrants based on the Black-Scholes option pricing valuation method, and an increase in notes payable of $ 719,539 as a result of reclassifying amounts previously recorded as discounts on notes payable, related to the warrants. F- 8 NOTE 3 – GOING CONCERN AND MANAGEMENT’S PLANS The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2021, the Company had an accumulated deficit of $ 217,326,611 and a working capital deficit of $ 28,225,908 (including derivative liabilities of $ 20,966,701 ). As of December 31, 2021, the Company was in default of $ 1,973,847 plus accrued interest on debt instruments due to non-payment upon maturity dates, and subsequent to December 31, 2021, an additional $ 13,310,000 plus accrued interest on debt instruments also were in default status due to non-payment upon maturity dates. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date of the issuance of these financial statements. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern. In December 2019, a novel strain of coronavirus (COVID-19) emerged. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time. Management’s Plans As a public company, Management believes it will be able to access the public equities market for fund raising for product development, sales and marketing and inventory requirements as we expand our distribution in the U.S. market. On October 14, 2021, the Company received a Notice of effectiveness related to the Company’s Form S-3 Registration Statement (the “Registration Statement”). Pursuant to the Registration Statement the Company may offer and sell from time to time in one or more offerings of up to thirty million dollars ($ 30,000,000 ) in aggregate offering price. We may offer these securities in amounts, at prices and on terms determined at the time of offering. As of the date of this Report the Company has not sold any securities pursuant to this Registration Statement. On April 4, 2022, the Company and GHS Investments LLC (“GHS”). signed a Securities Purchase Agreement (the “GHS Purchase Agreement”) for the sale of up to Two Hundred Million ( 200,000,000 ) shares of the Company’s common stock to GHS. We may sell shares of our common stock from time to time over a six (6)- month period ending October 4, 2022 , at our sole discretion, to GHS under the GHS Purchase Agreement. The purchase price shall be 85% of lowest VWAP for the ten (10) days preceding the Company’s notice to GHS for the sale of the Company’s common stock. On April 8, 2022, the Company filed a Prospectus Supplement to the Registration Statement dated October 14, 2021, regarding the GHS Purchase Agreement. The Company is in negotiations with its’ lenders related to the debt instruments that are currently in default, to extend the maturity dates. During the year ended December 31, 2021, the Company raised $ 28,100,000 (of which $ 11,250,000 was used to redeem Series C and Series D shares of preferred stock from Chis) and has begun to implement the following business operations, plans and strategies: OES is actively engaged in the renewable, electric vehicle (“EV”), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution. Our solar and energy storage projects involve large-scale battery and solar photovoltaics (PV) installations. Our utility-scale storage business model is based on an arbitrage business model in which we install multiple 1+ megawatt batteries, charge them with off-peak grid electricity under contract with the utility, then sell the power back during peak load hours at a premium, as dictated by prevailing electricity tariffs. Equipment Distributor: OES has entered the component supply/distribution side of the renewable, resiliency and energy storage industries distributing the core components associated with residential and commercial solar PV systems as well as onsite battery storage and power generation. In April 2021, the Company signed a five - year lease (beginning June 1, 2021) of approximately 8,100 SF in California, for office and warehouse space to support the sales and distribution of our west coast operations. The components we are distributing include PV panels, solar inverters, solar mounting systems, stationary batteries, onsite generators and other associated electrical equipment and components that are all manufactured by multiple companies, both domestic and international. These core products are sourced from management-developed relationships and are distributed through our existing network and our in-house sales team. Sales were approximately $ 10.6 million for the year ended December 31, 2021. F- 9 Solar PV: Our PV business model involves the design and construction of electrical generating PV systems that can sell power to the utilities or be used for off grid use as part of our developing Neo-Grids solution. The Neo-Grids proprietary program, patent pending, was developed for the off-grid distribution of electricity to remove or reduce the dependency on utilities that currently burdens the EV Charging sectors. It will also reduce or eliminate the lengthy permitting processes and streamline the installations of those EV chargers. Modular Energy Distribution System: The Neo-Grids, patent pending, is comprised of the design engineering, installation, and operational methodologies as well as the financial arbitrage of how we produce, capture and distribute electrical energy for the EV markets. : OES has acquired the license rights to a proprietary system, the Neo-Grids TM System (patent pending), for the capture and distribution of electrical energy for the EV market. The Neo-Grids TM System will serve both the private auto and the commercial sectors. The exponential growth of the EV industry has been accelerated by the recent major commitments of most of the major car manufacturers. Our Neo-Grids TM System leverages this accelerated growth by offering (1) charging locations that can be installed with reduced delays, restricted areas or load limits and (2) EV charger electricity that is produced from renewable sources claiming little to no carbon footprint. OES has developed a business plan for the Neo Grids distribution, a solution to the stress forthcoming to the existing grid infrastructure. The Company has completed its’ Neo Grid research and development as well as the first set of engineered technical drawings. This first stage of engineered technical drawings allows us to move forward with stage two, as well as to begin to construct the first prototype or proof of concept, (“PoC”). Our PoC design is partially reliant on auto manufacturers establishing standardizations of the actual charging/discharging protocols of the batteries such as on-board inverters as well as bi-directional capabilities in electric vehicles, which have only recently been established. As the market growth rate of EV’s continues to rise, the stress on the existing grid-tied infrastructure shows the need for the continued development of our Neo-Grid solution. OES management has decades of experience in the renewable, storage and resilient energy businesses and associated markets, which include but are not limited to project finance, project development, equipment finance, construction, utility protocol, regulatory policy and technology assessment. Ozop Plus plans on producing vehicle service contracts (“VSC’s”) for electric vehicles (EV’s). to respond to not only in filling the gap of a manufacturer’s warranty but to bring added value to EV owners by utilizing our partnerships and strengths in the renewable energy market to offer unique and innovative services. Among EV owners’ concerns are the EV battery repair and replacement costs, range anxiety, environmental responsibilities, roadside assistance, and the accelerated wear on additional components that EV vehicles experience. Management believes that the Ozop Plus VSC will give “peace of mind” to the EV buyer. The Company is currently in negotiations to complete the necessary agreements to launch the product in Q2 2022. Additionally, the Company is also in discussions with entities whereby Ozop Plus can re-insure the battery portion of another entity’s VSC. On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. (“OED”) a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide its’ customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs by working with architects, engineers, facility managers, electrical contractors and engineers. F- 10 NOTE 4 – SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS Basis of Presentation The accompanying consolidated financial statements are prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“US GAAP”). The consolidated financial statements include the accounts of the Company and Ozop Energy Systems, Inc. and the Company’s other wholly owned subsidiaries PCTI, Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”) and the Company’s majority owned subsidiary Ozop Capital Partners, Inc. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at December 31, 2021, and 2020. Sales Concentration and credit risk Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the years ended December 31, 2021, and 2020, and their accounts receivable balance as of December 31, 2021: SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR Sales % Year Ended December 31, 2021 Sales % Year Ended December 31, 2020 Accounts receivable balance December 31, 2021 Customer A 17 % N/A $ 782,179 Customer B N/A 62 % - Customer C N/A 15 % - For the year ended December 31, 2020, the above customers were of PCTI. PCTI, historically does not have year to year many recurring clients as the Company produces capital equipment for its’ customers. Accounts Receivable The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience. Inventory Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs include finished goods, material, labor and manufacturing overhead. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues. F- 11 The components of inventories at December 31, 2021, and 2020 are as follows: SCHEDULE OF INVENTORY December 31, 2021 December 31, 2020 Raw materials $ 234,168 $ 207,178 Work in process 43,704 142,526 Finished goods 788,110 9,643 Inventory net $ 1,065,982 $ 359,347 Purchase concentration OES purchases finished renewable energy products from its’ suppliers. For the year ended December 31, 2021, there were two suppliers that accounted for 42.6 % and 20.4 %, respectively. There are only a handful of major suppliers, and we currently have supply arrangements with some of those vendors. One of these vendors requires a 20 % down payment with the balances due on shipment and delivery, while other vendors terms are due immediately prior to delivery. We also buy product from other distributors, if we are not able to purchase direct from the manufacturer. While management believes all of its relationships with its vendors are good, if we are unable to continue to use and/or find alternative suppliers, when we cannot buy direct, it may have a material negative effect on our business. The principal purchases by PCTI are comprised of parts and raw materials that PCTI assembles and manufactures and sells to its customers. There were no suppliers who accounted for more than ten percent (10%) of PCTI’s purchases for the years ended December 31, 2021, and 2020. Suppliers to PCTI vary from period to period dependent upon our customer’s order specifications. In any specific reporting period, we may be relying on certain vendors, however these vendors will vary dependent on the parts and materials needed. PCTI believes it is not reliant on any particular vendor for future needs. Property, plant and equipment Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows: SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS Office furniture and equipment 3 - 5 years Warehouse equipment 7 years Revenue Recognition The Company recognizes revenue in accordance with ASC 606, from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. Under ASC 606, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. Other than The Company has no outstanding contracts with any of its’ customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms. For contracts with customers, ownership of the goods and associated revenue are transferred to customers at a point in time, generally upon shipment of a product to the customer or receipt of the product by the customer and without significant judgments. Advance payments are typically required for commercial customers and are recorded as current liability until revenue is recognized. Advance payments are not required for government customers. The majority of contracts typically require payment within 30 to 60 days after transfer of ownership to the customer. F- 12 For the periods covered herein, we did not have post shipment obligations such as training or installation, customer acceptance provisions, credits and discounts, rebates and price protection, or other similar privileges. The following table disaggregates our revenue by major source for the year ended December 31, 2021: DISAGGREGATION OF REVENUE Year ended December 31, 2021 Sourced and distributed products $ 10,595,799 Manufactured products 1,332,806 Total $ 11,928,605 Revenues from sourced and distributed products are purchased from suppliers as finished goods and the Company brings the finished goods into our California warehouse to fill orders as well as to build inventory for future sales orders. From time to time for some of our larger orders we may have our suppliers ship directly to our customers to avoid extra shipping charges. For manufactured products, there is usually a bidding process by branches of the military or other large firms that need mostly battery charging and storage systems for large industrial projects. We would then purchase the raw materials and parts needed to build out the project in our Pennsylvania warehouse. There was no disaggregation of revenues for the year ended December 31, 2020. Advertising and Marketing Expenses The Company expenses advertising and marketing costs as incurred. For the years ended December 31, 2021, and 2020, the Company recorded advertising and marketing expenses of $ 44,158 and $ 55,249 , respectively. Research and Development Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the years ended December 31, 2021, and 2020, the Company recorded $ 7,500 and - 0 - of research and development expenses. Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities. F- 13 Fair Value of Financial Instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. From time to time, certain of the Company’s embedded conversion features on debt and outstanding warrants have been treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to fully settle conversion features of the instruments if exercised. In this case, the Company utilized the latest inception date sequencing method to reclassify outstanding instruments as derivative instruments. These contracts were recognized at fair value with changes in fair value recognized in earnings until such time as the conditions giving rise to such derivative liability classification were settled. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments. The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of December 31, 2021 and 2020, for each fair value hierarchy level: SCHEDULE OF DERIVATIVE INSTRUMENTS December 31, 2021 Derivative Liabilities Total Level I $ - $ - Level II $ - $ - Level III $ 20,966,701 $ 20,966,701 December 31, 2020 Derivative Liabilities Total Level I $ - $ - Level II $ - $ - Level III $ 3,299,684 $ 3,299,684 F- 14 Leases The Company accounts for leases under ASU 2016-02 (see Note 14), applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assess whether the contract is, or contains, a lease. Our assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. We allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Operating lease ROU assets represent the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company used an incremental borrowing rate of 7.5 %, for the existing lease, based on the information available at the adoption date in determining the present value of future payments. Operating lease expense is recognized pursuant to on a straight-line basis over the lease term and is included in rent in the condensed consolidated statements of operations. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized. Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented. Segment Policy The Company has no reportable segments as it operates in one segment; renewable energy. Earnings (Loss) Per Share The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of December 31, 2021, and 2020, the Company’s dilutive securities are convertible into approximately 7,592,474,061 and 11,223,565,011 , respectively, shares of common stock. The following table represents the classes of dilutive securities as of December 31, 2021, and 2020: SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE December 31, 2021 December 31, 2020 Convertible preferred stock 6,918,544,466 10,193,874,467 Unexercised common stock purchase warrants 672,024,518 659,601,638 Convertible notes payable 1,905,077 370,087,556 Common stock to be issued - 1,350 7,592,474,061 11,223,565,011 F- 15 Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging —Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company does not believe the adoption of the ASU will have a material impact on the Company’s financial position, results of operations or cash flows. Other than the above, there have no recent accounting pronouncements or changes in accounting pronouncements during the period ended December 31, 2021, that are of significance or potential significance to the Company. NOTE 5 – PROPERTY AND EQUIPMENT The following table summarizes the Company’s property and equipment: PROPERTY AND EQUIPMENT December 31, 2021 December 31, 2020 Office equipment $ 260,083 $ 143,247 Less: Accumulated Depreciation ( 127,194 ) ( 82,576 ) Property and Equipment, Net $ 132,889 $ 60,671 Depreciation expense was $ 44,618 and $ 11,857 for the years ended December 31, 2021, and 2020, respectively. NOTE 6 - CONVERTIBLE NOTES PAYABLE The transaction with PCTI is being accounted for as a business combination and was treated as a reverse acquisition for accounting purposes with PCTI as the accounting acquirer in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”). In accordance with the accounting treatment for a reverse acquisition, the Company’s historical financial statements prior to the reverse merger were and will be replaced with the historical financial statements of PCTI prior to the reverse merger. The consolidated financial statements after completion of the reverse merger have and will include the assets, liabilities and results of operations of the combined company from and after the closing date of the reverse merger. On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a past-due 15% convertible note issued by the Company on September 13, 2017. As of December 31, 2021 and 2020, the outstanding principal balance of this note was $ 25,000 . On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a 12% convertible promissory note issued by the Company on June 1, 2020, (the “Issuance Date”) to an investor, pursuant to a Securities Purchase Agreement. This note matures 6 months after the Issuance Date . This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date . After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion . As of July 10, 2020, the outstanding principal balance of this note was $ 127,500 with a carrying value of $ 27,625 , net of unamortized discounts of $ 99,875 . In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $ 0.02 , subject to adjustments and expiring on the five -year anniversary of the Issuance Date. For the year December 31, 2021, the investor converted a total of $ 127,500 of the face value and $ 14,433 of accrued interest and fees into 88,708,118 shares of common stock at an average conversion price of $ 0.0016 . On March 10, 2021, the investor received 6,355,008 shares of common stock upon the cashless exercise of the warrants. As of December 31, 2021, and 2020, the outstanding principal balance of this note was $- 0 - and $ 127,500 , respectively. F- 16 On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a 15% convertible promissory note issued by the Company on June 30, 2020, (the “Issuance Date”) to an investor, pursuant to a Securities Purchase Agreement. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $ 0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion . As of July 10, 2020, the outstanding principal balance of this note was $ 129,500 with a carrying value of $ 8,375 , net of unamortized discounts of $ 121,125 . In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $ 0.02 , subject to adjustments and expiring on the five -year anniversary of the Issuance Date. For the year December 31, 2021, the investor converted a total of $ 129,500 of the face value and $ 30,264 of accrued interest and fees into 110,946,972 shares of common stock at an average conversion price of $ 0.00144 . On March 10, 2021, the investor received 6,355,008 shares of common stock upon the cashless exercise of the warrants. As of December 31, 2021, and 2020, the outstanding principal balance of this note was $- 0 - and $ 129,500 , respectively, with a carrying value of $ 111,763 as of December 31, 2020, net of unamortized discounts of $ 10,416 . On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a 15 % convertible promissory note issued by the Company on July 8, 2020, (the “Issuance Date”) to an investor, pursuant to a Securities Purchase Agreement. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date . After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion . In conjunction with this note, the Company issued a warrant to purchase 12,500,000 shares of common stock at an exercise price of $ 0.02 , subject to adjustments and expiring on the five -year anniversary of the Issuance Date. For the nine months ended December 31, 2021, amortization of the debt discounts of $ 10,416 was charged to interest expense. For the year December 31, 2021, the investor converted a total of $ 250,000 of the face value and $ 130,044 of accrued interest and fees into 243,012,455 shares of common stock at an average conversion price of $ 0.00156 . On March 10, 2021, the investor received 12,460,800 shares of common stock upon the cashless exercise of the warrants. As of December 31, 2021, and December 31, 2020, the outstanding principal balance of this note was $- 0 - and $ 250,000 , respectively, with a carrying value of $ 239,583 as of December 31, 2020, net of unamortized discounts of $ 10,416 . On February 26, 2020, (the “Issuance Date”) PCTI issued a 12 % Convertible Promissory Note (the “Note”), in the principal amount of $ 106,950 , to an investor. This note matures 12 months after the Issuance Date . This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at 55 % of the lowest trading price for the twenty-five trading days prior to the conversion. If the trading price cannot be calculated for such security on such date, the trading price shall be the fair market value as mutually determined by the Company and the investor for which the calculation of the trading price is required in order to determine the conversion price. PCTI received proceeds of $ 85,000 on February 26, 2020, and the Note included an original issue discount of $ 13,950 and lender costs of $ 8,000 . This note proceeds were used by the Company for general working capital purposes. The Note also required a daily payment via ACH of $ 400 . On June 25, 2020, the Note was amended to add $ 111,225 of additional principal to the outstanding balance. Pursuant to the PCTI transaction with Ozop, on July 10, 2020, the conversion price is equal to 45 % multiplied by the lowest closing bid price during the twenty-five-trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. Accordingly, the Company determined the conversion feature of the Notes represented an embedded derivative since the note is convertible into a variable number of shares upon conversion, as the note was not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability. The embedded feature included in the note resulted in an initial debt discount of $ 85,000 , interest expense of $ 135,786 and initial derivative liability of $ 220,786 . For the year ended December 31, 2021, amortization of the debt discounts of $ 17,737 was charged to interest expense. For the year December 31, 2021, the investor converted a total of $ 50,550 of the face value and $ 11,265 of accrued interest and fees into 20,218,562 shares of common stock at an average conversion price of $ 0.00306 . The Investor also amended the note to deduct the previously added principal amount of $ 111,225 . As of December 31, 2021, and 2020, the outstanding principal balance of this note was $- 0 - and $ 161,775 , respectively. The Company accounted for the amendment as an extinguishment of debt. F- 17 On July 15, 2020, (the “Issuance Date”) the Company issued a 15 % convertible promissory note, in the principal amount of $ 127,500 , to an investor. This note matures 6 months after the Issuance Date . This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date . After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion . The Company received proceeds of $ 102,000 on July 22, 2020, and this note included an original issue discount of $ 25,500 . This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $ 0.02 , subject to adjustments and expiring on the five -year anniversary of the Issuance Date. The Company allocated the proceeds to the debt of $ 82,068 and to the warrant $ 19,932 based on the relative fair value. The embedded conversion feature included in this note resulted in an initial derivative liability of $ 207,699 , a debt discount of $ 82,068 with the excess of $ 125,541 charged to interest expense of $ 125,541 . On March 10, 2021, the investor received 6,355,008 shares of common stock upon the cashless exercise of the warrants. For the year ended December 31, 2021, amortization of the debt discounts of $ 10,792 was charged to interest expense. On May 6, 2021, the Company and the investor entered into a Settlement and Mutual Release Agreement (the “Settlement Agreement”). Pursuant to the Settlement Agreement, the investor agreed to cancel the July 15, 2020, note. The Company accounted for the cancelled note as a gain on debt extinguishment. As of December 31, 2021, and December 31, 2020, the outstanding principal balance of this note was $- 0 - and $ 127,500 , respectively, with a carrying value of $ 116,708 , net of unamortized discounts of $ 10,792 as of December 31, 2020. On July 29, 2020, (the “Issuance Date”) the Company issued a 15 % convertible promissory note, in the principal amount of $ 127,500 , to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date . After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion . The Company received proceeds of $ 100,000 on August 3, 2020, and this note included an original issue discount of $ 25,500 . This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 12,750,000 shares of common stock at an exercise price of $ 0.01 , subject to adjustments and expiring on the five -year anniversary of the Issuance Date. The Company allocated the proceeds to the debt $ 61,733 and warrant $ 40,267 based on the relative fair value. The embedded conversion feature included in this note resulted in an initial derivative liability of $ 198,239 , a debt discount of $ 61,733 with the excess of $ 136,506 charged to interest expense. On March 10, 2021, the investor received 12,710,016 shares of common stock upon the cashless exercise of the warrants. For the year ended December 31, 2021, amortization of the debt discounts of $ 21,583 was charged to interest expense. On May 6, 2021, the investor, pursuant to the Settlement Agreement, agreed to cancel the July 29, 2020, note. The Company accounted for the cancelled note as a gain on debt extinguishment. As of December 31, 2021, and 2020, the outstanding principal balance of this note was $- 0 - and $ 127,500 with a carrying value of $ 105,917 , net of unamortized discounts of $ 21,583 as of December 31, 2020. On November 16, 2020, (the “Issuance Date”) the Company issued a promissory note, in the principal amount of $ 250,000 , to an investor. The note carries a guaranteed interest payment of 15 %, which is added to the principal on the Issuance Date. Principal payments shall be made in six instalments of $ 57,500 commencing May 21, 2021, and continuing each 30 days thereafter for 4 months. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $ 0.01 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.01 or the volume weighted average price of the common stock during the five (5) Trading Day period ending on the day prior to conversion . The Company received proceeds of $ 200,000 on November 19, 2020, and this note included an original issue discount of $ 50,000 . This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial derivative liability of $ 14,750 and a debt discount of $ 50,000 . In conjunction with this note, the Company issued a warrant to purchase 35,000,000 shares of common stock at an exercise price of $ 0.25 , subject to adjustments and expiring on the five -year anniversary of the Issuance Date. The warrants issued resulted in a debt discount of $ 3,050 , with the offset to additional paid in capital. For the year ended December 31, 2021, amortization of the debt discounts of $ 59,264 was charged to interest expense. On May 6, 2021, the investor, pursuant to the Settlement Agreement, agreed to cancel the November 16, 2020, note and the warrant to purchase 35,000,000 shares. The Company accounted for the cancelled note and warrant as a gain on debt extinguishment. As of December 31, 2021, and December 31, 2020, the outstanding principal balance of this note was $- 0 - and $ 250,000 with a carrying value of $ 190,736 , as of December 31, 2020, net of unamortized discounts of $ 59,264 . F- 18 A summary of the convertible note balance as of December 31, 2021, and 2020, is as follows: SCHEDULE OF DEBT December 31, 2021 December 31, 2020 Principal balance $ 25,000 $ 1,198,775 Unamortized discount - ( 119,790 ) Ending balance, net $ 25,000 $ 1,078,985 NOTE 7 – DERIVATIVE LIABILITIES The Company determined the conversion feature of the convertible notes, which all contain variable conversion rates, represented an embedded derivative since the notes were convertible into a variable number of shares upon conversion. Accordingly, the notes are not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability. At any given time, certain of the Company’s embedded conversion features on debt and outstanding warrants may be treated as derivative liabilities for accounting purposes under ASC 815-40 due to insufficient authorized shares to settle these outstanding contracts. Pursuant to SEC staff guidance that permits a sequencing approach based on the use of ASC 815-15-25 which provides guidance for contracts that permit partial net share settlement. The sequencing approach may be applied in one of two ways: contracts may be evaluated based on (1) earliest issuance date or (2) latest maturity date. Pursuant to the sequencing approach, the Company evaluates its contracts based upon the latest maturity date. The Company valued the derivative liabilities at December 31, 2021, and 2020, at $ 20,966,701 and $ 3,299,684 , respectively. For the derivative liability associated with convertible notes, the Company used the Monte Carlo simulation valuation model with the following assumptions as of December 31, 2021, and 2020, risk free interest rates at 0.19 % and 0.09 %, respectively, and volatility of 92 % and 48 % to 61 %, respectively. During the year ended December 31, 2021, the Company issued 375,000,000 warrants in conjunction with notes payable (see Note 8). Due to insufficient authorized shares (see above), the Company recorded a discount to notes payable of $ 14,982,815 and interest expense of $ 38,907,939 , with the offset to derivative liabilities for the initial fair value of the warrants based on the Black-Scholes option pricing method of $ 53,890,754 . The following assumptions were utilized in the Black-Scholes valuation, risk free interest rate of .48 % to .99 %, volatility of 344 % to 366 %, and exercise prices of $ 0.039 to $ 0.15 . The Company revaluated the warrants outstanding at December 31, 2020, and based on the insufficient authorized shares, the Company determined that the warrants should have been classified as a liability, The accompanying financial statements have been adjusted to reflect the change from an equity classification to a liability classification (see Note 2). A summary of the activity related to derivative liabilities for the years ended December 31, 2021, and 2020, is as follows: SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE Derivative liabilities associated with warrants Derivative liabilities associated with convertible notes Total derivative liabilities Balance- July 10, 2020, assumed pursuant to PCTI transaction $ - $ 8,743,231 $ 8,743,231 Issued during period 2,061,307 641,285 2,702,592 Converted or paid - ( 8,322,188 ) ( 8,322,188 ) Change in fair value recognized in operations - 176,049 176,049 Balance December 31, 2020 $ 2,061,307 $ 1,238,377 $ 3,299,684 Fair value of issuances during period 53,890,754 - 53,890,754 Notes converted or paid - ( 2,246,114 ) ( 2,246,114 ) Exercise of warrants ( 48,110,301 ) - ( 48,110,301 ) Warrants cancelled ( 3,216,397 ) - ( 3,216,397 ) Change in fair value 16,313,392 1,035,683 17,349,075 Balance December 31, 2021 $ 20,938,755 $ 27,946 $ 20,966,701 F- 19 NOTE 8 – NOTES PAYABLE The Company has the following note payables outstanding: SCHEDULE OF NOTES PAYABLE December 31, 2021 December 31, 2020 $ 134,681 $ 151,469 Note payable bank, interest at 7.75 %, matured December 5, 2021 , currently in default $ 134,681 $ 151,469 Note payable bank, interest at 6.5 %, matures December 26, 2021 , in default 344,166 345,211 Economic Injury Disaster Loan 10,000 10,000 Paycheck Protection Program loan 100,400 100,400 Notes payable, interest at 8 %, matured January 5, 2020 , in default 45,000 45,000 Other, due on demand, interest at 6 %, currently in default 50,000 50,000 Note payable $ 203,000 face value, interest at 12 %, matured June 25, 2021 , net of discount of $ 13,185 at December 31, 2020 - 189,815 Note payable $ 750,000 face value, interest at 12 %, matured August 24, 2021 , net of discount of $ 540,562 (2020), in default 375,000 209,438 Note payable $ 389,423 face value, interest at 18 %, matures November 6, 2023 389,423 389,423 Note payable $ 1,000,000 face value, interest at 12 %, matures November 13, 2021 , net of discount of $ 971,250 (2020), in default 1,000,000 28,750 Note payable $ 2,200,000 face value, interest at 12 %, matures February 9, 2022 , net of discount of $ 243,833 1,956,167 - Note payable $ 11,110,000 face value, interest at 12 %, matures March 17, 2022 , net of discount of $ 2,314,583 8,795,417 - Note payable $ 3,300,000 face value, interest at 12 %, matures December 7, 2022 , net of discount of $ 3,099,524 200,476 Sub- total notes payable 13,400,730 1,519,506 Less long-term portion 389,423 389,423 Current portion of notes payable, net of discount $ 13,011,307 $ 1,130,083 On December 7, 2021, the Company entered into a 12 %, $ 3,300,000 face value promissory note with a third- party lender with a maturity date of December 7, 2022 . In exchange for the issuance of the $ 3,300,000 note, inclusive of an original issue discount of $ 300,000 , the Company received proceeds of $ 3,000,000 on December 13, 2021, from the lender. In conjunction with the note, the Company issued a warrant to purchase 75,000,000 shares of common stock at $ 0.039 per share (subject to adjustments) with an expiry date on the three- year anniversary of the note. For the year ended December 31, 2021, amortization of the costs of $ 16,750 was charged to interest expense. The fair value of the warrant calculated by the Black- Scholes option pricing method of $ 2,982,815 has been recorded as an initial debt and an initial derivative liability of $ 2,982,815 . For the year ended December 31, 2021, amortization of the warrant discount of $ 166,540 was charged to interest expense. As of December 31, 2021, the outstanding principal balance of this note was $ 3,300,000 with a carrying value of $ 200,476 , net of unamortized discounts of $ 3,099,524 . F- 20 On March 17, 2021, the Company entered into a 12 %, $ 11,110,000 face value promissory note with a third- party lender with a maturity date of March 17, 2022 . In exchange for the issuance of the $ 11,110,000 note, inclusive of an original issue discount of $ 1,000,000 and lender costs of $ 110,000 the Company received proceeds of $ 10,000,000 on March 23, 2021, from the lender. In conjunction with the note, the Company issued a warrant to purchase 250,000,000 shares of common stock at $ 0.13 per share (subject to adjustments) with an expiry date on the three- year anniversary of the note. For the year ended December 31, 2021, amortization of the costs of $ 878,750 was charged to interest expense. The fair value of the warrant calculated by the Black- Scholes option pricing method of $ 33,248,433 has been recorded as an initial debt discount of $ 10,000,000 , interest expense of $ 23,248,433 and initial derivative liability of $ 32,248,433 . For the year ended December 31, 2021, amortization of the warrant discount of $ 7,916,667 was charged to interest expense. As of December 31, 2021, the outstanding principal balance of this note was $ 11,110,000 with a carrying value of $ 8,795,417 , net of unamortized discounts of $ 2,314,583 . The Company is in discussions with the lender regarding the extension of the maturity date of this note. On February 9, 2021, the Company entered into a 12 %, $ 2,200,000 face value promissory note with a third- party lender with a maturity date of February 9, 2022 . In exchange for the issuance of the $ 2,200,000 note, inclusive of an original issue discount of $ 200,000 the Company received proceeds of $ 2,000,000 on February 16, 2021, from the lender. In conjunction with the note, the Company issued a warrant to purchase 50,000,000 shares of common stock at $ 0.15 per share (subject to adjustments) with an expiry date on the three- year anniversary of the note. For the year ended December 31, 2021, amortization of the costs of $ 177,833 was charged to interest expense. The fair value of the warrant calculated by the Black- Scholes option pricing method of $ 17,659,506 has been recorded as an initial debt discount of $ 2,000,000 , interest expense of $ 15,659,506 and initial derivative liability of $ 17,659,506 . For the year ended December 31, 2021, amortization of the warrant discount of $ 1,778,333 was charged to interest expense. As of December 31, 2021, the outstanding principal balance of this note was $ 2,200,000 with a carrying value of $ 1,956,167 , net of unamortized discounts of $ 243,833 . The Company is in discussions with the lender regarding the extension of the maturity date of this note. On November 13, 2020, the Company entered into a 12 %, $ 1,000,000 face value promissory note with a third-party due November 13, 2021 . Principal payments shall be made in six instalments of $166,667 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date . The Company received proceeds of $ 890,000 on November 20, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 110,000 . For the year ended December 31, 2021, amortization of the costs of $ 96,250 was charged to interest expense. In conjunction with this note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 125,000,000 shares of common stock at an exercise price of $ 0.008 , subject to adjustments and expires on the five -year anniversary of the issue date. The warrants issued resulted in a debt discount of $ 1,000,000 . For the year ended December 31, 2021, amortization of the warrant discount of $ 875,000 was charged to interest expense. As of December 31, 2021, and December 31, 2020, the outstanding principal balance of this note was $ 1,000,000 with a carrying value of $ 1,000,000 and $ 28,750 , respectively, net of unamortized discounts of $ 971,250 . This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of December 31, 2021, the accrued interest is $ 135,452 . The Company is in discussions with the lender regarding the extension of the maturity date of this note. On November 6, 2020, the Company entered into a Settlement Agreement with the holder of $ 120,000 of convertible notes with accrued and unpaid interest of $ 8,716 and a $ 210,000 Promissory Noted dated June 23, 2020 with accrued and unpaid interest of $ 15,707 . The Company issued a new 12 % Promissory Note with a face value of $ 389,423 and a maturity date of November 6, 2023 . In conjunction with this settlement, the Company issued a warrant to purchase 60,000,000 shares of common stock at an exercise price of $ 0.0075 , subject to adjustments and expires on the five -year anniversary of the issue date. The Company analyzed the transaction and concluded that this was a modification to the existing debt. The investor exercised the warrant on January 14, 2021. On October 26, 2016, PCTI entered into a $ 210,000 note payable with a bank. On March 15, 2021, due to defaults with the terms of the note, the note was amended with the outstanding balance due December 5, 2021, and the interest rate changed to 7.75 %. Borrowings are collateralized by substantially all of the assets of PCTI and the personal guarantee of PCTI’s former President. As of December 31, 2021, and December 31, 2020, $ 134,681 and $ 151,469 , respectively, was outstanding on the note payable. This note is in default. F- 21 On March 15, 2021, PCTI renewed their $ 350,000 promissory note with a bank that provides for borrowings of up to $ 350,000 . Interest is due monthly and the principal is due on December 26, 2021 , interest rate changed to the prime rate plus 3.25 % ( 6.5 % at March 15, 2021). Borrowings are collateralized by substantially all of the assets of PCTI and the personal guarantee of PCTI’s former President. As of December 31, 2021, and December 31, 2020, $ 344,166 and $ 345,211 , respectively, was outstanding on the promissory note. This note is in default. On August 24, 2020 (the “Issue Date”), the Company entered into a 12 %, $ 750,000 face value promissory note with a third-party (the “Holder”) due August 24, 2021 (the “Maturity Date”). Principal payments shall be made in six instalments of $125,000 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date . The Company received proceeds of $ 663,000 on August 25, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 87,000 . For the year ended December 31, 2021, amortization of the costs of $ 56,188 was charged to interest expense. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 122,950,819 shares of common stock at an exercise price of $ 0.0061 , subject to adjustments and expires on the five -year anniversary of the Issue Date. The warrants issued resulted in a debt discount of $ 750,000 . For the year ended December 31, 2021, amortization of the debt discount of $ 484,376 was charged to interest expense. During the year ended December 31, 2021, the Company paid $ 375,000 to the Holder. On May 3, 2021, the Company issued 75,000,000 shares of common stock to the Holder, upon the cashless exercise of a portion of the warrants. As of December 31, 2021, and 2020, the outstanding principal balance of this note was $ 375,000 and $ 750,000 , respectively, with a carrying value of $ 375,000 and $ 209,438 , net of unamortized discounts of $ 540,562 as of December 31, 2020. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of December 31, 2021, the accrued interest is $ 90,247 . The Company is in discussions with the lender regarding the extension of the maturity date of this note. On April 20, 2020, PCTI was granted a loan from Huntington Bank in the amount of $ 100,400 , pursuant to the Paycheck Protection Program (“PPP”) under Division A, Title I of the CARES Act, which was enacted March 27, 2020. The loan matures on April 20, 2022 and bears interest at a rate of 1.0 % per annum, payable monthly beginning on November 20, 2020. The loan may be prepaid at any time prior to maturity with no prepayment penalties. Payments are deferred until the SBA determines the amount to be forgiven. The Company utilized the proceeds of the PPP loan in a manner which will enable qualification as a forgivable loan. On March 26, 2021, the Company received notice from Huntington Bank the they have determined that PCTI’s loan forgiveness application has been approved and has been submitted to the SBA. On December 2, 2021, PCTI received a notice from Huntington Bank that the SBA has denied PCTI’s application for loan forgiveness, due to inaccurate statements in the loan application as submitted by the former CEO of PCTI. The balance on this PPP loan was $ 100,400 as of December 31, 2021, and 2020 and has been classified in notes payable. On July 14, 2020, PCTI received $ 10,000 grant under the Economic Injury Disaster Loan (“EIDL”) program. Up to $ 10,000 of the EIDL can be forgiven as long as such funds were utilized to provide working capital. The first payment due is deferred one year. The loan as of December 31, 2021, and 2020 and has been classified in notes payable . The following note was assumed on July 10, 2020, pursuant to the PCTI transaction: On June 25, 2020, the Company entered into a 12 %, $ 203,000 face value promissory note with a third-party lender with a maturity date of June 25, 2021 . Principal payments shall be made in six instalments of $33,333 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the issuance date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date . The Company received proceeds of $ 176,000 on June 26, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 27,000 . For the year ended December 31, 2021, amortization of the costs of $ 13,185 was charged to interest expense. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 10,000,000 shares of common stock at an exercise price of $ 0.02 , subject to adjustments and expires on the five -year anniversary of the Issue Date. During the year ended December 31, 2021, the investor converted a total of $ 203,000 of the face value and $ 15,899 of accrued interest and fees into 20,268,511 shares of common stock at an average conversion price of $ 0.0108 . On January 8, 2021, and January 15, 2021, the investor received 100,668,692 and 9,121,265 shares of common stock, respectively, upon the cashless exercise of the warrants. As of December 31, 2021, and December 31, 2020, the outstanding principal balance of this note was $- 0 - and $ 203,000 , respectively. F- 22 NOTE 9 – DEFERRED LIABILITY On September 2, 2020, PCTI entered into an agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $ 750,000 , PCTI agreed to pay the third-party a perpetual three percent ( 3 %) payment of revenues, as defined in the agreement. Payments are due ninety (90) days after each calendar quarter, with the first payment due on or before March 31, 2021, for revenues for the quarter ending December 31, 2020. The Company has recorded the $ 750,000 as deferred liability on the December 31, 2021, and 2020, consolidated balance sheet. No payments have been made and the Company is in default of the agreement. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the note was amended, whereby in exchange for 175,000,000 shares of common stock, the royalty percentage was amended to 1.8 %. The Company valued the shares at $ 0.094 per share (the market value of the common stock on the date of the agreement) and recorded $ 16,450,000 as debt restructure expense on the consolidated statement of operations for the year ended December 31, 2021. As of December 31, 2021, the Company has recorded an expense and a liability of $ 215,151 on the consolidated financial statements. NOTE 10 – DEFERRED REVENUE During the year ended December 31, 2020, the Company received $ 64,353 form a customer for a payment of a three- year extended warranty . The extended warranty period is from, March 2021 through February 2024, and accordingly the Company will recognize the revenue over such period. For the year ended December 31, 2021, the Company recognized $ 17,876 , of revenue. Of the remaining deferred revenue of $ 46,477 , $ 21,451 is recognized as the current portion of deferred revenue and $ 25,026 is classified as a long- term liability on the consolidated financial statements. As of December 31, 2020, $ 17,876 is classified as the current portion and $ 46,477 is classified as a long- term liability on the consolidated financial statements. NOTE 11 – RELATED PARTY TRANSACTIONS Employment Agreement On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the “Employment Agreement”). Pursuant to the terms of the Employment Agreement, Mr. Conway is to receive an initial annual salary of $ 120,000 , for his position of CEO of the Company, payable monthly. Mr. Conway was issued 2,500 shares of Series C Preferred Stock. The Company valued the shares at $ 5,000 . On August 28, 2020, Mr. Conway was issued 1,333 shares of Series D Preferred stock and 500 shares of Series E Preferred Stock. The aggregate shares of Series D Preferred Stock in its entirety, is convertible into one and one-half times the number of shares of common stock outstanding at the time of conversion. On August 28, 2020, Mr. Conway owned 6.67 % of the issued and outstanding Series D Preferred Stock, and based on the 3,107,037,634 shares outstanding on August 28, 2020, Mr. Conway’s Preferred Stock was convertible into 621,253,401 shares of common stock. Based on the share price of the common stock on that date of $ 0.0065 , the shares were valued at $ 4,286,648 and recognized as compensation during the year ended December 31, 2020. Effective January 1, 2021, Mr. Conway’s compensation is $ 20,000 per month, and effective September 1, 2021, Mr. Conway is receiving $ 10,000 per month from Ozop Capital. F- 23 Series E Preferred Stock On March 21, 2021, the Company issued 2,000 shares of Series E Preferred Stock (see Note 12), 1,800 of the shares were issued to Mr. Conway. Pursuant to the terms and conditions of the Certificate of Designation of the Series E Preferred Stock, including the redemption value of $ 1,000 per share, the Company recorded $ 1,800,000 as stock compensation expense for the Series E shares issued to Mr. Conway. On April 16, 2021, the Board of Directors (the “BOD”) of the Company authorized the issuance 2,000 shares of Series E Preferred stock, of which 1,050 were issued to Mr. Conway. The Company recorded $ 1,050,000 of expense related to the shares issued to Mr. Conway. During the year ended December 31, 2021, the Company redeemed the 2,850 shares issued to Mr. Conway. Management Fees and related party payables For the years ended December 31, 2021, and 2020, the Company recorded expenses to its officers in the following amounts: SCHEDULE OF EXPENSES TO OFFICERS 2021 2020 Year ended December 31, 2021 2020 CEO, parent (includes $ 5,000 stock-based compensation year ended December 31, 2020) $ 812,099 $ 377,804 CEO, parent- Series E Preferred Stock 2,850,000 - CEO, parent- Series D Preferred Stock - 4,286,648 President, subsidiary (resigned July 2021) 141,666 83,500 Total $ 3,803,765 $ 4,747,952 As of December 31, 2020, included in related party payable is $ 9,120 for the amount owed the former President of PCTI (resigned in July 2021). Redemption of Series C and Series D Preferred Stock On July 13, 2021, the Company entered into a Definitive Agreement (the “Agreement”) with Chis to purchase the 47,500 shares of the Company’s Series C Preferred Stock held by Chis and the 18,667 shares of the Company’s Series D Preferred Stock held by Chis for the total purchase price of $ 11,250,000 . In conjunction with the Agreement, Chis resigned from any and all positions held in the Company’s wholly owned subsidiary, PCTI. Further, Chis agreed that upon her resignation and for a period of five years thereafter (the “Restriction Period”), she shall not, directly or indirectly, solicit the employment of, assist in the soliciting of the employment of, or hire any employee or officer of the Company, including those of any of its present or future subsidiaries, or induce any person who is an employee, officer, agent, consultant or contractor of the Company to terminate such relationship with the Company. Additionally, Chis agreed that during the Restriction Period, she shall not compete with the Company or PCTI anywhere worldwide or be employed by any competitor of the Company. NOTE 12 – COMMITMENTS AND CONTINGENCIES Leases On January 2, 2021, the Company entered into a ten ( 10 ) year lease for a 6-bay garage storage facility of approximately 2,500 square feet. Pursuant to the lease the Company agreed to issue 100,000,000 shares of restricted common stock. The shares were certificated on March 8, 2021, with an effective date of January 2, 2021. The Company valued the shares $ 0.0063 , (the market value of the common stock on the date of the agreement) and has recorded $ 630,000 as a prepaid expense. The Company has not yet taken occupancy of the space, Agreements On September 1, 2021, Ozop Capital entered into an advisory agreement (the “RMA Agreement”) with Risk Management Advisors, Inc. (“RMA”). Pursuant to the terms of the RMA Agreement, RMA will assist Ozop Capital in analyzing, structuring, and coordinating Ozop Capital’s participation in a captive insurance company. RMA will coordinate legal, accounting, tax, actuarial and other services necessary to implement the Company’s participation in a captive insurance company, including, but not limited to, the preparation of an actuarial feasibility study, filing of all required regulatory applications, domicile selection, structural selection, and coordination of the preparation of legal documentation. In connection with the services listed above, Ozop Capital agreed to pay $ 50,000 and to issue $ 50,000 of shares of restricted common stock. One-half of the cash and stock were due upon the signing of the RMA Agreement. Accordingly, RMA received $ 25,000 and 452,080 shares of restricted common stock of the Company in September 2021. The balance of the cash and stock became due on October 29, 2021, upon the issuance of the captive insurance company’s certificate of authority from the state of Delaware. The Company paid the $ 5,000 balance and recorded 637,755 shares of common stock to be issued. For the year ended December 31, 2021, the Company recorded $ 50,000 as stock compensation expense. F- 24 On April 13, 2021, the Company agreed to engage PJN Strategies, LLC (“PJN”) as a consultant. Pursuant to the agreement, the Company agreed to compensate PJN $ 20,000 per month. Effective September 1, 2021, a new agreement was entered into between PJN and Ozop Capital. Pursuant to the terms of the new one- year agreement Ozop Capital agreed to compensate PJN $ 84,000 per month. For the year ended December 31, 2021, the Company recorded $ 436,000 ,of consulting expenses. On April 16, 2021, the Company signed a letter of agreement with Rubenstein Public Relations, Inc. (“RPR”). Pursuant to the letter of agreement, the Company agreed to engage RPR, effective May 1, 2021, on a month-to-month basis for $ 17,000 per month. For the year ended December 31, 2021, the Company recorded $ 102,000 of consulting expenses. The Company terminated the agreement in October 2021. On March 30, 2021, OES hired 2 individuals as Co-Directors of Sales. Pursuant to their respective offers of employment, the Company agreed to an annual salary of $ 130,000 with a signing bonus of $ 20,000 for each and to issue each 2,500,000 shares of restricted common stock upon the execution of the agreements and every 90 days thereafter for the first year as long as the employee is still employed. The Company valued the initial shares at $ 0.092 per share (the market price of the common stock on the date of the agreement), and $ 460,000 is included in stock-based compensation expense for the year ended December 31, 2021. On July 1, 2021, the Company issued each of the Co-Directors the 2,500,000 shares due after the first ninety days of employment. The shares were valued at $ 0.0745 per share (the market price of the common stock on the date of the issuance), and $ 372,500 is included in stock-based compensation expense for the year ended December 31, 2021. On October 1, 2021, the Company issued each of the Co-Directors the 2,500,000 shares due after the first one hundred eighty days of employment. The shares were valued at $ 0.0445 per share (the market price of the common stock on the date of the issuance), and $ 227,500 is included in stock-based compensation expense for the year ended December 31, 2021. One of the individuals resigned on January 24, 2022. On March 15, 2021, the Company entered into a consulting agreement with Aurora Enterprises (“Aurora”). Mr. Steven Martello is a principal of Aurora. Pursuant to the agreement Mr. Martello will provide strategic analysis regarding existing markets and revenue streams as well as the development of new lines of revenue. The Company agreed to a monthly retainer fee of $ 10,000 and to issue to Aurora or their designee 5,000,000 shares of restricted common stock. The shares were issued in April 2021. Aurora designated the shares to be issued to Pegasus Partners, Inc. The Company valued the shares at $ 0.1392 per share (the market price of the common stock on the date of the agreement), and $ 696,000 is included in stock-based compensation expense for the year ended December 31, 2021. For the year ended December 31, 2021, the Company has recorded $ 90,000 of consulting expenses. On February 24, 2021, the Company entered into a consulting agreement with Christopher Ruppel. Pursuant to the agreement Mr. Ruppel was to join the Ozop Advisory Board. During the year ended December 31, 2021, the Company issued 10,000,000 shares of restricted common stock to Mr. Ruppel and agreed to a monthly fee of $ 2,500 . The Company valued the shares at $ 0.2386 per share (the market price of the common stock on the date of the agreement), and $ 2,386,000 is included in stock-based compensation expense for the year ended December 31, 2021. Effective April 1, 2021, the agreement was amended to $ 10,000 per month. Effective May 1, 2021, the Company was no longer using the services of Mr. Ruppel. For the year ended December 31, 2021, the Company recorded $ 12,500 of consulting expenses. On February 19, 2021, the Company entered into a Joint Business Alliance agreement with Grid and Energy Master Planning, LLC (“GEMM”). GEMM will provide advisory, financing and implementation solutions for behind-the-meter customers in the areas of energy efficiency, solar, EV charging, and battery storage for OES. The GEMM services allows OES to provide one-stop-shopping in these emerging and maturing sectors. As of December 31, 2021, there has not been any transactions related to this agreement and the Company is continuing to evaluate the accounting treatment of any future transactions. F- 25 On January 22, 2021, the Company issued 10,000,000 shares of restricted common stock for legal services performed in 2020 and approved by the BOD of the Company on December 1, 2020. The Company valued the shares at $ 0.0056 per share (the market price of the common stock on the date of the agreement), and $ 56,000 is included in stock-based compensation expense for the year ended December 31, 2021. On January 14, 2021, the Company entered into a Consulting Agreement with Mr. Allen Sosis. Pursuant to the agreement, Mr. Sosis will provide services as the Director of Business Development for the Company’s wholly owned subsidiary. Pursuant to the agreement, as amended, the Company will pay Mr. Sosis a monthly fee of $ 15,000 and an additional $ 1,000 in benefits. The Company also agreed to issue Mr. Sosis 5,000,000 shares of restricted common stock. The shares were issued in April 2021. The Company valued the shares at $ 0.20 per share (the market price of the common stock on the date of the agreement), and $ 1,000,000 was recorded as deferred stock compensation, to be amortized over the one-year term of the agreement. The Company terminated Mr. Sosis’s employment in October 2021, and accordingly, for the year ended December 31, 2021, $ 1,000,000 is included in stock-based compensation expense. For the year ended December 31, 2021, the Company recorded $ 75,500 of consulting expenses, and effective June 1, 2021, Mr. Sosis became an employee of the Company through his termination with a $ 15,000 per month salary. On January 6, 2021, the Company entered into a consulting agreement with Ezra Green to begin on February 8, 2021. The Company agreed to issue 10,000,000 shares of restricted common stock to Mr. Green and to a monthly fee of $ 2,500 . The Company valued the shares at $ 0.0076 per share (the market price of the common stock on the date of the agreement), and $ 76,000 was recorded as deferred stock-based compensation, to be amortized over the one-year term of the agreement. For the year ended December 31, 2021, the Company recorded $ 74,751 as stock-based compensation expense. Effective April 1, 2021, the agreement was amended to $ 10,000 per month. On March 9, 2021, Mr. Green filed a provisional patent with the USPTO. The provisional patent covers proprietary methods and procedures that, will allow the expansion of OES into the EV charging and support industry. The provisional patent relates to the more efficient production, distribution, and delivery of energy, particularly renewable energy, to the EV end consumer and enables OES to build the support systems for such. For the year ended December 31, 2021, the Company recorded $ 94,500 of consulting expenses. On March 4, 2019, the Company entered into a Separation Agreement (the “Separation Agreement”) with Salman J. Chaudhry, pursuant to which the Company agreed to pay Mr. Chaudry $ 227,200 (the “Outstanding Fees”) in certain increments as set forth in the Separation Agreement. As of December 31, 2021 and 2020, the balance owed Mr. Chaudhry is $ 162,085 . On September 2, 2020, PCTI entered into an Agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $ 750,000 , PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement . On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the agreement was amended, whereby in exchange for 175,000,000 shares of common stock, the royalty percentage was amended to 1.8 % (see Note 9). The Company valued the shares at $ 0.094 per share (the market value of the common stock on the date of the agreement) and recorded $ 16,450,000 as debt restructure expense on the consolidated statement of operations for the year ended December 31, 2021. As of December 31, 2021, the Company has recorded $ 215,171 and is included in accounts payable and accrued expenses on the consolidated balance sheet presented herein. Legal matters We know of no material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest. F- 26 NOTE 13– STOCKHOLDERS’ EQUITY Common stock During the period from January 1, 2021, to December 31, 2021, holders of an aggregate of $ 760,550 in principal and $ 201,905 of accrued interest and fees of convertible and promissory notes, converted their debt into 483,154,618 shares of our common stock at an average conversion price of $ 0.002 per share. During the year ended December 31, 2021, the Company also issued the following shares of restricted common stock: ● 100,000,000 shares of restricted common stock pursuant to a lease agreement (see Note 10). ● 175,000000 shares of restricted common stock pursuant to restructuring agreement related to a deferred liability (see Note 9). ● 55,452,080 shares of restricted common stock in the aggregate for services and consulting agreements. During the year ended December 31, 2021, the Company also issued 405,797,987 shares of common stock upon the cashless exercise of common stock purchase warrants. As of December 31, 2021, the Company has 4,990,000,000 shares of $ 0.001 par value common stock authorized and there are 4,617,362,997 shares of common stock issued and outstanding. Preferred stock As of December 31, 2021, 10,000,000 shares have been authorized as preferred stock, par value $ 0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time. Series C Preferred Stock On July 7, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series C Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company’s preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no conversion rights and no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote . On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 47,500 shares of Series C preferred Stock to Chis. On July 13, 2021, the Company purchased 47,500 shares of the Company’s Series C Preferred Stock held by Chis (see Note 11). As of December 31, 2021, and 2020, there were 2,500 and 50,000 shares, respectively, of Series C Preferred Stock issued and outstanding, of which 2,500 shares are held by Mr. Conway. Series D Preferred Stock On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. Under the terms of the Certificate of Designation of Series D Preferred Stock, 20,000 shares of the Company’s preferred stock have been designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. The holders as a group may, at any time convert all of the shares of Series D Convertible Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 3. Except as provided in the Certificate of Designation or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights. On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 18,667 shares of Series D preferred Stock to Chis, and on August 28, 2020, pursuant to Mr. Conway’s employment agreement, the Company issued 1,333 shares of Series D Preferred Stock to Mr. Conway. Accordingly, on August 28, 2020, Mr. Conway owned 6.67 % of the issued and outstanding Series D Preferred Stock, and based on the 3,107,037,634 shares outstanding on August 28, 2020, Mr. Conway’s Preferred Stock was convertible into 621,253,401 shares of common stock. Based on the share price of the common stock on that date of $ 0.0065 , the shares were valued at $ 4,286,648 . On July 13, 2021, the Company purchased 18,667 shares of the Company’s Series D Preferred Stock held by Chis (see Note 11). F- 27 On July 27, 2021, the Company filed with the Secretary of State of the State of Nevada an Amended and Restated Certificate of Designation of Series D Preferred Stock (the “Series D Amendment”). Under the terms of the Series D Amendment, 4,570 shares of the Company’s preferred stock will be designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. Any holder may, at any time convert any number of shares of Series D Convertible Preferred Stock held by such holder into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 1.5 and dividing that number by the number of authorized shares of Series D Convertible Preferred Stock multiplied by the number of shares of Series D Convertible Preferred Stock being converted. Except as provided in the Series D Amendment or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights. On July 28, 2021, the Company closed on a Stock and Warrant Purchase Agreement (the “Series D SPA”). Pursuant to the terms of Series D SPA, an investor in exchange for $ 13,200,000 purchased one share of Series D Preferred Stock, and a warrant to acquire 3,236 shares of Series D Preferred Stock. As of December 31, 2021, and 2020, there were 1,334 and 20,000 shares, respectively, of Series D Preferred Stock issued and outstanding and warrants to purchase 3,236 shares of Series D Preferred Stock are outstanding as of December 31, 2021. The warrant has a 15 - year term and Partial Warrant Lock Up and Leak-Out Period. The Holder may only exercise the Warrant and purchase Warrant Shares as follows: i. Up to 162 (one hundred and sixty-two) Warrant Shares, at any time or times on or after the Initial Exercise Date and no later than on or before the Termination Date; and ii. The Remainder of the Warrant representing up to 3,074 (three thousand and seventy-four) Warrant Shares (“Remaining Warrant Shares”) shall be locked up for a period of 36 (thirty-six) months from the Initial Exercise Date (“Lock Up Period”) and shall become exercisable at any time or times from the date that is the 36 (thirty-six) month anniversary of the Initial Exercise Date (“Lock Up Period Termination Date”) and no later than on or before the Termination Date, as follows: a. During every 1(one) year period, starting on the day that is the Lock Up Period Termination Date, the Holder shall have the right to exercise the Remainder of the Warrant up to a maximum number of Remaining Warrant Shares that, if converted, would be equal to no more than a maximum of 5% (five percent) of the total number of outstanding shares of Common Stock of the Company during such given year (“Leak-Out Period”). The Leak-Out Period shall come into effect on the day that is the Lock Up Period Termination Date and remain effective on a yearly basis, for a period of 10 (ten) years thereafter, after which the Leak-Out Period will automatically terminate and become null and void. For clarity purposes the Remainder of the Warrant shall become freely exercisable at any time or times beginning on June 29, 2034 and until the Termination Date . F- 28 Series E Preferred Stock On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series E Preferred Stock. Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000 shares of the Company’s preferred stock have been designated as Series E Preferred Stock. The holders of the Series E Convertible Preferred Stock shall not be entitled to receive dividends. No holder of the Series E Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation for their vote, waiver, release or other action, except as may be otherwise expressly required by law. At any time, the Corporation may redeem for cash out of funds legally available therefor, any or all of the outstanding Preferred Stock (“Optional Redemption”) at $ 1,000 (one thousand dollars) per share. The shares of Series E Preferred Stock have not been registered under the Securities Act of 1933 or the laws of any state of the United States and may not be transferred without such registration or an exemption from registration. On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 500 shares of Series E preferred Stock to Chis, and on August 28, 2020. Pursuant to Mr. Conway’s employment agreement, the Company issued 500 shares of Series E Preferred Stock to Mr. Conway. On March 2, 2021, the BOD authorized the issuance of 1,800 shares of Series E Preferred Stock to Mr. Conway and 200 shares of Series E Preferred Stock to a third-party service provider. The issuances were for services performed. Pursuant to the terms and conditions of the Certificate of Designation of the Series E Preferred Stock, including the redemption value of $ 1,000 per share, the Company recorded $ 2,000,000 as stock-based compensation expense for year ended December 31, 2021. On March 24, 2021, the Company redeemed the 3,000 shares of Series E Preferred Stock outstanding on that date. On April 16, 2021, the BOD authorized the issuance of 2,000 shares of Series E Preferred stock, of which 1,050 were granted to Mr. Conway. The issuances were for services performed. Pursuant to the terms and conditions of the Certificate of Designation of the Series E Preferred Stock, including the redemption value of $ 1,000 per share, the Company recorded $ 2,000,000 as stock-based compensation expense for the year ended December 31, 2021. As of December 31, 2021, and 2020, there were - 0 - and 1,000 shares of Series E Preferred Stock issued and outstanding, respectively. NOTE 14 – NONCONTROLLING INTEREST On August 19, 2021, the Company formed Ozop Capital. Upon formation, the Company owned 51 % with PJN owning 49 %. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital. The Company presents interest held by noncontrolling interest holders within noncontrolling interest in the consolidated financial statements. During the year ended December 31, 2021, there was no change in the ownership percentages. For the year ended December 31, 2021, Ozop Capital incurred a loss of $ 520,623 , of which $ 255,105 is the loss attributed to the noncontrolling interest. NOTE 15 - OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES On October 25, 2019, PCTI executed a non-cancellable lease for office and industrial space which began December 1, 2019 and expires on November 30, 2022 . Operating lease right-of-use assets and liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5 %, as the interest rate implicit in most of our leases is not readily determinable. Prior to July 10, 2020, PCTI recorded monthly lease expense pursuant to the lease agreement and effective July 10, 2020, pursuant to the PCTI transaction, operating lease expense is recognized pursuant to ASC Topic 842. Leases (Topic 842) over the lease term. During the years ended December 31, 2020, the Company recorded $ 84,278 for rent expense. During the year ended December 31, 2020, upon adoption of ASC Topic 842, the Company recorded right-of-use assets and lease liabilities of $ 185,139 for this lease. On April 14, 2021, the Company entered into a five -year lease which began on June 1, 2021, for approximately 8,100 square feet of office and warehouse space in Carlsbad, California, expiring May 31, 2026 . Initial lease payments of $ 13,148 begin on June 1, 2021, and increase by approximately 2.4 % annually thereafter. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5 %, as the interest rate implicit in most of our leases is not readily determinable. During the six months ended June 1, 2021, upon adoption of ASC Topic 842, the Company recorded right-of-use assets and lease liabilities of $ 702,888 for this lease. In adopting Topic 842, the Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. F- 29 Right-of- use assets are summarized below: SCHEDULE OF RIGHT-OF-USE ASSETS December 31, 2021 Office and warehouse lease $ 888,026 Less accumulated amortization ( 180,340 ) Right-of-us assets, net $ 707,686 Operating lease liabilities are summarized as follows: SCHEDULE OF OPERATING LEASE LIABILITIES December 31, 2021 Lease liability $ 712,256 Less current portion ( 194,366 ) Long term portion $ 517,890 Maturity of lease liabilities are as follows: SCHEDULE OF MATURITY OF LEASE LIABILITIES Amount For the year ending December 31, 2022 $ 240,991 For the year ending December 31, 2023 167,858 For the year ended December 31, 2024 171,840 For the year ended December 31, 2025 175,942 For the year ended December 31, 2026 74,030 Total $ 830,661 Less: present value discount ( 118,405 ) Lease liability $ 712,256 NOTE 16 – SUBSEQUENT EVENTS Effective January 1, 2022, the Company entered into a new employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway received a $ 250,000 contract renewal bonus and will receive an annual compensation of $ 240,000 from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company’s subsidiaries. Ozop Capital began compensating Mr. Conway $ 20,000 per month in January 2022 and OES began compensating Mr. Conway $ 20,000 in March 2022. On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. (“OED”) a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs. We work with architects, engineers, facility managers, electrical contractors and engineers. On April 4th, 2022, the Company and GHS Investments LLC (“GHS”). signed a Securities Purchase Agreement (the “GHS Purchase Agreement”) for the sale of up to Two Hundred Million ( 200,000,000 ) shares of the Company’s common stock to GHS. We may sell shares of our common stock from time to time over a six (6)- month period ending October 4, 2022 , at our sole discretion, to GHS under the GHS Purchase Agreement. The purchase price shall be 85% of lowest VWAP for the ten (10) days preceding the Company’s notice to GHS for the sale of the Company’s common stock. On April 8, 2022, the Company filed a Prospectus Supplement to the Registration Statement dated October 14, 2021, regarding the GHS Purchase Agreement. The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein. F- 30